Kidney health is a vital component of overall health and the ability of the body to function properly. Kidney health is especially important for those with chronic kidney disease or those at risk of developing it. Fractional excretion of sodium (FENa) is a test used to measure the amount of sodium that is excreted in the urine. This test is used to help diagnose and monitor kidney problems, as well as to assess the effectiveness of treatments. In this article, we will explore the benefits of FENa for improved kidney health.
FENa is a test used to measure the amount of sodium that is excreted in the urine. It is a simple test that can be done in the doctor’s office or at home. The test measures the amount of sodium that is filtered out of the blood and then excreted in the urine. This test helps to identify problems with the kidneys, such as decreased kidney function, that can be caused by a variety of conditions, including diabetes, high blood pressure, and heart disease.
FENa helps to identify problems with the kidneys, such as decreased kidney function, that can be caused by a variety of conditions. By measuring the amount of sodium that is excreted in the urine, the test can help to identify if there is a problem with the kidneys. If the amount of sodium excreted is too low, it may indicate that the kidneys are not functioning properly and need to be evaluated. FENa can also help to monitor the effectiveness of treatments for kidney problems. By measuring the amount of sodium that is excreted in the urine, the doctor can determine if the treatment is working or if it needs to be adjusted. This can help to ensure that the patient is receiving the best possible care.
FENa can help to identify and monitor kidney problems, as well as to assess the effectiveness of treatments. This test is quick, simple, and non-invasive, and can provide valuable information about the health of the kidneys. FENa can also help to identify potential problems before they become serious. By measuring the amount of sodium that is excreted in the urine, the doctor can determine if there is a problem with the kidneys. This can help to catch kidney problems early, before they become more serious.
FENa is a simple test that can help to identify and monitor kidney problems, as well as to assess the effectiveness of treatments. This test is quick, simple, and non-invasive, and can provide valuable information about the health of the kidneys. By measuring the amount of sodium that is excreted in the urine, the doctor can determine if there is a problem with the kidneys, as well as to monitor the effectiveness of treatments. FENa can help to identify potential problems before they become serious, and can help to ensure that the patient is receiving the best possible care.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation